Press

News from the Lung Institute

Press Contact: Communications Team
Phone: (877) 867-4551
Communications@lunginstitute.com

Lung Institute Nationally Recognized by the Joint Commission and Awarded Ambulatory Health Care Accreditation

Tampa, Florida, Jan. 30, 2018 – Lung Institute, a provider of cellular therapy therapy to patients with developing or developed COPD and under the medical management company Regenerative Medicine Solutions, today announced it has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally recognized standards….

Read More >

Other Press Articles

the-lung-institute-a-leader-in-cellular-therapy-for-treatment-of-lung-disease-wins-tampa-small-business-excellence-award
the-lung-institute-donation-helps-employees-son-run-in-aau-national-track-meet
Lung Institute Applauds Texas Medical Freedom Act

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.